跳至主要内容
临床试验/NCT06270537
NCT06270537招募中不适用

Multicenter Study Collecting Post-market Clinical Data on the Dominus® Stent-Graft for Treating Thoracic Aortic Diseases

Braile Biomedica Ind. Com. e Repr. Ltda.3 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年10月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
3
主要终点
Early occurrence of adverse events (Safety Outcome)

研究概览

简要总结

Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use

详细描述

The multicenter study aims to collect post-market clinical data on the Dominus® Stent-Graft in the treatment of thoracic aortic diseases. With the goal of assessing safety and efficacy, the prospective follow-up study will include 100 patients undergoing Endovascular Treatment of Thoracic Aortic Diseases, following the product's Instructions for Use

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older;
  • Patients treated with the Dominus® Stent-Graft Endoprosthesis in accordance with its Instructions for Use;
  • Patient available for appropriate follow-up times for the study duration;
  • Informed patient about the nature of the study, agreeing to its provisions, and signing the informed consent.

排除标准

  • Patient currently participating in another clinical study of drug or medical device;
  • Life expectancy less than 12 months.

结局指标

主要结局

Early occurrence of adverse events (Safety Outcome)

时间窗: 1 month post index procedure

Early rate Major Adverse Events (MAEs), including all-cause mortality, acute myocardial infarction (AMI), stroke, permanent paraplegia, and recent-onset renal failure (requiring dialysis).

次要结局

  • Device Success(Intraoperative)
  • Absence of endoprosthesis fracture(1 month and 1 year)
  • Endoleak(At the end of surgery/procedure, 1 month, 6 month, 1, 2, 3, 4 and 5 years)
  • Reintervention-free(At the end of surgery/procedure, 1 month, 6 month, 1, 2, 3, 4 and 5 years)
  • Adverse Events(At the end of surgery/procedure, 1 month, 6 month, 1, 2, 3, 4 and 5 years)

研究者

发起方
Braile Biomedica Ind. Com. e Repr. Ltda.
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验